Goldman Sachs’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.12B | Buy |
7,837,182
+1,647,946
| +27% | +$491M | 0.24% | 61 |
|
|
2025
Q4 | $2.04B | Buy |
6,189,236
+988,896
| +19% | +$335M | 0.25% | 54 |
|
|
2025
Q3 | $1.8B | Sell |
5,200,340
-1,797,349
| -26% | -$544M | 0.22% | 67 |
|
|
2025
Q2 | $2.18B | Buy |
6,997,689
+1,164,283
| +20% | +$445M | 0.3% | 48 |
|
|
2025
Q1 | $3.06B | Sell |
5,833,406
-1,141,809
| -16% | -$584M | 0.49% | 25 |
|
|
2024
Q4 | $3.53B | Buy |
6,975,215
+1,649,085
| +31% | +$937M | 0.56% | 24 |
|
|
2024
Q3 | $3.11B | Buy |
5,326,130
+392,100
| +8% | +$222M | 0.5% | 24 |
|
|
2024
Q2 | $2.51B | Sell |
4,934,030
-501,861
| -9% | -$246M | 0.42% | 31 |
|
|
2024
Q1 | $2.69B | Sell |
5,435,891
-172,846
| -3% | -$87.9M | 0.48% | 27 |
|
|
2023
Q4 | $2.95B | Buy |
5,608,737
+134,381
| +2% | +$71.7M | 0.54% | 22 |
|
|
2023
Q3 | $2.76B | Buy |
5,474,356
+637,568
| +13% | +$314M | 0.59% | 21 |
|
|
2023
Q2 | $2.32B | Buy |
4,836,788
+133,994
| +3% | +$65.5M | 0.5% | 29 |
|
|
2023
Q1 | $2.22B | Buy |
4,702,794
+10,485
| +0.2% | +$5.06M | 0.51% | 23 |
|
|
2022
Q4 | $2.49B | Sell |
4,692,309
-152,716
| -3% | -$80.9M | 0.61% | 13 |
|
|
2022
Q3 | $2.45B | Sell |
4,845,025
-25,683
| -0.5% | -$13.5M | 0.62% | 16 |
|
|
2022
Q2 | $2.5B | Buy |
4,870,708
+791,654
| +19% | +$398M | 0.63% | 17 |
|
|
2022
Q1 | $2.08B | Buy |
4,079,054
+446,190
| +12% | +$215M | 0.44% | 27 |
|
|
2021
Q4 | $1.82B | Sell |
3,632,864
-176,775
| -5% | -$80M | 0.36% | 34 |
|
|
2021
Q3 | $1.49B | Buy |
3,809,639
+463,733
| +14% | +$192M | 0.32% | 43 |
|
|
2021
Q2 | $1.34B | Sell |
3,345,906
-84,228
| -2% | -$33.6M | 0.3% | 47 |
|
|
2021
Q1 | $1.28B | Buy |
3,430,134
+111,765
| +3% | +$38.7M | 0.32% | 41 |
|
|
2020
Q4 | $1.16B | Buy |
3,318,369
+90,227
| +3% | +$30.2M | 0.3% | 46 |
|
|
2020
Q3 | $1.01B | Sell |
3,228,142
-666,807
| -17% | -$205M | 0.29% | 47 |
|
|
2020
Q2 | $1.15B | Sell |
3,894,949
-942,897
| -19% | -$270M | 0.35% | 39 |
|
|
2020
Q1 | $1.21B | Sell |
4,837,846
-818,878
| -14% | -$225M | 0.43% | 28 |
|
|
2019
Q4 | $1.66B | Buy |
5,656,724
+595,577
| +12% | +$156M | 0.42% | 28 |
|
|
2019
Q3 | $1.1B | Buy |
5,061,147
+314,430
| +7% | +$75.9M | 0.32% | 46 |
|
|
2019
Q2 | $1.16B | Buy |
4,746,717
+504,165
| +12% | +$121M | 0.33% | 41 |
|
|
2019
Q1 | $1.05B | Sell |
4,242,552
-377,174
| -8% | -$96.2M | 0.32% | 43 |
|
|
2018
Q4 | $1.15B | Sell |
4,619,726
-381,697
| -8% | -$101M | 0.37% | 36 |
|
|
2018
Q3 | $1.33B | Buy |
5,001,423
+93,814
| +2% | +$24.4M | 0.34% | 35 |
|
|
2018
Q2 | $1.2B | Sell |
4,907,609
-1,225,365
| -20% | -$294M | 0.33% | 39 |
|
|
2018
Q1 | $1.31B | Sell |
6,132,974
-244,142
| -4% | -$55.8M | 0.34% | 32 |
|
|
2017
Q4 | $1.41B | Buy |
6,377,116
+1,392,754
| +28% | +$295M | 0.34% | 33 |
|
|
2017
Q3 | $976M | Sell |
4,984,362
-230,844
| -4% | -$44.6M | 0.24% | 54 |
|
|
2017
Q2 | $967M | Buy |
5,215,206
+524,457
| +11% | +$92M | 0.25% | 51 |
|
|
2017
Q1 | $769M | Buy |
4,690,749
+42,981
| +0.9% | +$7.04M | 0.21% | 73 |
|
|
2016
Q4 | $744M | Buy |
4,647,768
+1,601,800
| +53% | +$239M | 0.21% | 65 |
|
|
2016
Q3 | $426M | Sell |
3,045,968
-57,941
| -2% | -$8.12M | 0.13% | 133 |
|
|
2016
Q2 | $438M | Buy |
3,103,909
+199,082
| +7% | +$26.5M | 0.14% | 109 |
|
|
2016
Q1 | $374M | Sell |
2,904,827
-88,448
| -3% | -$10.5M | 0.12% | 140 |
|
|
2015
Q4 | $352M | Buy |
2,993,275
+9,238
| +0.3% | +$1.08M | 0.11% | 179 |
|
|
2015
Q3 | $346M | Sell |
2,984,037
-888,705
| -23% | -$106M | 0.12% | 157 |
|
|
2015
Q2 | $472M | Sell |
3,872,742
-956,259
| -20% | -$113M | 0.15% | 129 |
|
|
2015
Q1 | $571M | Buy |
4,829,001
+61,466
| +1% | +$6.83M | 0.18% | 92 |
|
|
2014
Q4 | $482M | Buy |
4,767,535
+260,894
| +6% | +$24.7M | 0.15% | 113 |
|
|
2014
Q3 | $389M | Sell |
4,506,641
-1,535,221
| -25% | -$130M | 0.12% | 142 |
|
|
2014
Q2 | $494M | Sell |
6,041,862
-582,142
| -9% | -$45.8M | 0.15% | 114 |
|
|
2014
Q1 | $543M | Sell |
6,624,004
-1,402,476
| -17% | -$106M | 0.18% | 97 |
|
|
2013
Q4 | $604M | Buy |
8,026,480
+1,720,822
| +27% | +$124M | 0.2% | 88 |
|
|
2013
Q3 | $452M | Buy |
6,305,658
+406,849
| +7% | +$29.1M | 0.17% | 110 |
|
|
2013
Q2 | $386M | Buy |
+5,898,809
| New | +$367M | 0.15% | 124 |
|
Other funds holding UNH
VCM
VPM
Goldman Sachs's UNH Position: Q1 2026 in Review
Goldman Sachs increased its UnitedHealth (UNH) stake by 27% in Q1 2026, buying an estimated $491M and bringing the position to 7,837,182 shares worth $2.12B. The position accounts for 0.24% of the portfolio, ranked #61.
Goldman Sachs first reported a position in UNH in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.53B in Q4 2024. 3,019 funds tracked by Wall St. Rank hold UNH as of Q1 2026.
- Goldman Sachs held 7,837,182 shares of UnitedHealth worth $2.12B as of Q1 2026.
- Goldman Sachs bought 1,647,946 UnitedHealth shares in Q1 2026, an estimated $491M.
- UnitedHealth made up 0.24% of Goldman Sachs's portfolio in Q1 2026, its #61 holding.
- Goldman Sachs first reported a position in UnitedHealth in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's UnitedHealth position peaked at $3.53B in Q4 2024.
- 3,019 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.